In response to the Covid-19 pandemic, Mazars Global Financial Advisory Services team has surveyed private equity fund managers and other investors in this asset class to understand their challenges and concerns, gauge their level of optimism for the future and hear about their response strategy. In this webinar we present the results of the survey analysing the response strategies, as well as expectations on deal flow/new investments, managing current portfolios, realizing exit strategies and expectations on the recovery with special focus on private equity in the CEE region. Furthermore, the webinar will provide valuable expert advice on how to value companies in times of crisis such as COVID-19 pandemic. What are the right techniques in assessing the value of new investment opportunities or realizing the exit strategies for private equity funds? Mazars Global Financial Advisory Services team has prepared the special report on valuation in times of crisis and most important insights and practical advice will be presented during the webinar.

The COVID-19 crisis has been accelerating change we already knew we needed to make in healthcare. Recent developments are likely to have a lasting impact on healthcare as a sector, and all the supporting infrastructure around it. What will this mean for Private Equity Investors and how are they thinking about value creation given the current disruption in the marketplace?

Since COVID-19 hit the market, private equity firms have seen the valuation of their portfolio diminish substantially, lowering the potential returns to their investors. Firms have been forced to take proactive actions in order to withstand the financial impact, and also the ESG associated questions this pandemic has brought along with it. Learn more about ESG webinar; Staying sustainable.

This webinar will discuss Direct vs. Co-Investing; pros and cons. Leading experts will join the webinar; Joaquin Alexandre Ruiz Tarre, Head of Co-Investments, Secondaries and Special Situations from European Investment Fund, Michael Lints partner at GoldenGate Ventures, Nico Taverna, partner at Mill Reef Capital and Jason Sotero, CEO at Private Equity Insights. Register to join professionals in private equity.

The COVID-19 crisis has been accelerating change we already knew we needed to make in healthcare:  shift to telemedicine and telehealth, remote clinical trials, shortened lab-to-market timelines for vaccines and drugs.